Last reviewed · How we verify

6 L dialysate

Shanghai Jiao Tong University School of Medicine · FDA-approved active Small molecule Quality 5/100

6 L dialysate is a Small molecule drug developed by Shanghai Jiao Tong University School of Medicine. It is currently FDA-approved.

At a glance

Generic name6 L dialysate
SponsorShanghai Jiao Tong University School of Medicine
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 6 L dialysate

What is 6 L dialysate?

6 L dialysate is a Small molecule drug developed by Shanghai Jiao Tong University School of Medicine.

Who makes 6 L dialysate?

6 L dialysate is developed and marketed by Shanghai Jiao Tong University School of Medicine (see full Shanghai Jiao Tong University School of Medicine pipeline at /company/shanghai-jiao-tong-university-school-of-medicine).

What development phase is 6 L dialysate in?

6 L dialysate is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing